Are longitudinal randomised controlled oral health trials properly analysed? A meta-epidemiological study.


Journal

Journal of dentistry
ISSN: 1879-176X
Titre abrégé: J Dent
Pays: England
ID NLM: 0354422

Informations de publication

Date de publication:
09 2022
Historique:
received: 27 03 2022
revised: 06 06 2022
accepted: 08 06 2022
pubmed: 13 6 2022
medline: 24 8 2022
entrez: 12 6 2022
Statut: ppublish

Résumé

Longitudinal designs with multiple outcome measurements are commonly encountered in oral health randomised controlled trials (RCTs). The aim of this meta epidemiological study was to assess whether optimal statistical analysis approaches have been used in longitudinal oral health RCTs. PubMed search was undertaken in September 2021 for longitudinal oral health RCTs with at least 3 repeated outcome measurements which have been published between 2016 and 2020 in the highest impact general and specialty dental journals. Study selection and data extraction were accomplished independently and in duplicate. The statistical methods undertaken in the selected articles were tabulated, and the association between study characteristics and use of optimal analyses were assessed using X Five hundred and five oral health RCTs were deemed eligible for inclusion. Of these, only 28.3% RCTs used optimal statistical analyses for a longitudinal trial design. For the trials with an optimal statistical approach, the most frequent test used was repeated measures analysis of variance (RM-ANOVA) followed by mixed effect models (MEM). The use of optimal statistical tests was predicated by the involvement of a statistician (OR: 2, 95% CI:1.27-3.18, p < 0.01), the journal impact factor (OR:1.19, 95% CI;1.1-1.29), continent of first author (likelihood ratio test p = 0.01), number of the authors (OR:1.22, 95% CI;1.12-1.3, p < 0.001), protocol registration (OR: 1.48, 95%CI; 1 to 2.2, p = 0.05), funding(OR:2.4, 95%CI; 1.6-3.7, p < 0.001), and dental specialty (likelihood ratio test p < 0.001). Most longitudinal oral health RCTs did not use optimal statistical analyses. Greater awareness of optimal analyses used to assess longitudinal data reported in oral health trials is required to circumvent the reporting of suboptimal inferences, selective reporting and research waste. Further progress is required to avoid suboptimal statistical analyses and fully utilise the benefits of the repeated measurements over time in oral health RCTs.

Identifiants

pubmed: 35691454
pii: S0300-5712(22)00238-X
doi: 10.1016/j.jdent.2022.104182
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104182

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Auteurs

Samer Mheissen (S)

Syrian Board in Orthodontics, Former instructor in Orthodontic Department, Syrian Ministry of Health, Specialist Orthodontist in Private Practice, Damascus, Syria. Electronic address: Mheissen@yahoo.com.

Haris Khan (H)

CMH institute of dentistry Lahore, National University of Medical Sciences, Punjab, Pakistan.

Jadbinder Seehra (J)

Centre for Craniofacial Development and Regeneration, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, Floor 25, Guy's Hospital, London SE1 9RT, United Kingdom.

Nikolaos Pandis (N)

Department of Orthodontics and Dentofacial Orthopedics, Dental School/Medical Faculty, University of Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH